to revenue from sale ratio is 73.24 %, 70.82 % and 77.04 %, for year 2020, 2021, and 2022 respectively. The main reason is that in 2022, the company has increased variable costs such as raw material
Gain from change in a joint venture proportion 9.87 9.87 0.00 0.00 Other income 9.60 (1.28) 11.40 (1.11) Total income 799.34 5.83 806.22 (13.57) The Company wish to explain the main reasons change of
year which a net loss of 12.88 million baht, the decreased loss of 6.94 million baht, the main reasons are as follow; 1. Revenue from sale , Other income The company had sale revenue at the end of
increased 121.20 million baht or 11% from 1,111.90 million baht in the nine months of year 2017 to 1,233.10 million baht in the nine months of year 2018. The main increase was derived from the engineering
632% by compared with the net profit at 47.13 million baht same period at last year. The changing over than 20% from the main causes as follows: 1. Revenue from the sale of 1.30 increase 1.10 million
increase 240.90 million baht or 855% by compared with the net profit at 28.16 million baht same period at last year. The changing over than 20% from the main causes as follows: 1. Revenue from the sale of
main factor that company increased the net profit was expanded the market and increased new clients. It could let the revenue increased by 9% (6% from Asia region, 2% from Europe region and 1% from
% from the same period of last year which was THB 117.42 million, the main factors that contributed to the increase in revenue were the number of visits and the attendance of both inpatients and
the plants in Quarter 1/2018. 2. Sales cost to revenue ratio increased by 6.72% (from 89.71% to 96.43%). The main factors were that the price of raw material has been increased during Quarter 1/2018